Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide.

Exogenous cholecystokinin selectively antagonizes opiate analgesia, which suggests that endogenous cholecystokinin may act physiologically as an opiate antagonist and may play a role in opiate tolerance. The use of the selective cholecystokinin antagonist proglumide provided a test of these hypotheses in rats that were either inexperienced with or tolerant to opiates. Proglumide potentiated analgesia produced by morphine and endogenous opiates and seemed to reverse tolerance. These results suggest that endogenous cholecystokinin systems oppose the action of opiates.

[1]  B. Bunney,et al.  Proglumide: selective antagonism of excitatory effects of cholecystokinin in central nervous system. , 1983, Science.

[2]  L. Watkins,et al.  Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. , 1983, Science.

[3]  L. Watkins,et al.  Organization of endogenous opiate and nonopiate pain control systems. , 1982, Science.

[4]  L. Watkins,et al.  Failure of spinal cord serotonin depletion to alter analgesia elicited from the periaqueductal gray , 1982, Brain Research.

[5]  R. Jensen,et al.  Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Zetler Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8) , 1980, Neuropharmacology.

[7]  J. Rehfeld,et al.  Gastrin and cholecystokinin in central and peripheral neurons. , 1979, Federation proceedings.

[8]  Donald D. Price,et al.  Antagonism of acupuncture analgesia in man by the narcotic antagonist naloxone , 1977, Brain Research.

[9]  E. J. Simon,et al.  Distribution of stereospecific binding of the potent narcotic analgesic etorphine in the human brain: predominance in the limbic system. , 1973, Research communications in chemical pathology and pharmacology.

[10]  H. Akil,et al.  Antagonism of stimulation-produced analgesia by p-CPA, a serotonin synthesis inhibitor. , 1972, Brain research.

[11]  Fred E. D'Amour,et al.  A METHOD FOR DETERMINING LOSS OF PAIN SENSATION , 1941 .